Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04543552
Other study ID # H-1709-045-883
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 13, 2017
Est. completion date May 1, 2021

Study information

Verified date July 2020
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

As a part of the urodynamic studies, urinary catheterization is inserted to measure residual urine, however, it has shown to be an invasive procedure, cause urinary tract infection, and traumatic experience. Bladder scan has been introduced as an alternative and non-invasive method to measure urine residual in the bladder.


Description:

Functional urinary disorders are common as more than 15% of children are diagnosed. During the normal course of urinary tract development, bladder and urinary sphincter develop by 2 to 4 years old, and by five years old, the tract is completely developed. The underdevelopment of the urinary tract may lead to complications of the bladder and kidneys along with social impairment. Therefore, the diagnosis is critical as an early diagnosis can prevent long term complications. To diagnose, newborns undergo basic urinalysis, urine culture examination, blood creatinine analysis, and kidney and bladder ultrasound. If any abnormalities are present at the under the age of five, it is recommended that they are followed up on a regular basis. Also, urodynamic studies should be performed every year along with others for early identification and intervention. Studies have shown that UDS (urodynamic studies) significantly reduce the deterioration of the bladder and kidney and the need for operation such as bladder dilation. As a part of the urodynamic studies, urinary catheterization is inserted to measure residual urine, however, it has shown to be an invasive procedure, which can cause urinary tract infection. The bladder scanner is an ultrasonic imaging device that has been developed for non-invasive measurement of residual volume in the bladder. The images and measurements are obtained by applying a probe onto the abdomen. It constructs 12 cross-sectional images at 15 degree interval using the reflection signals from urine in the bladder and extracts the position of the bladder wall. The objective of the study is to assess the validity of existing pediatric algorithms for diagnosing neurogenic bladder and evaluate the accuracy of measuring the post-void residual volume between the ages of 0 to 6 years old. It hypothesizes that when the portable bladder scanner (Bladder Scanner, Biocon-900) is used in pediatric population between the ages of 0 to 3 years old will show greater difference in infused and scanned volume than 4 to 6 years old.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date May 1, 2021
Est. primary completion date April 29, 2021
Accepts healthy volunteers No
Gender All
Age group 1 Month to 6 Years
Eligibility Inclusion Criteria: - Under the age of 6 years old. - Urodynamic study is scheduled to due to suspected changes in the bladder function or shape. - Those who understand and sign the informed consent form. Exclusion Criteria: - Subjects with surgical history of the bladder. - Constant leaking of the urine due to bladder neck contracture. - Any congenital abnormalities that induce changes in the shape of the bladder. - Unsuitable to participate in the study at the discretion of the principal investigator.

Study Design


Intervention

Device:
Bladder scan
Bladder Scanner, or Biocon-900 is an ultrasonic imaging device that has been developed to measure post-void residual volume of the bladder non-invasively. The images and measurements are obtained by applying a probe onto the abdomen (i.e. bladder). As it scans, the scanner constructs 12 cross-sectional images at 15 degree interval using the reflection signals from urine in the bladder and extracts the position of the bladder wall as well. During urodynamic studies, the bladder scan will measure the infused volume in order to assess difference between the infused and scanned volumes.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Scanned bladder volume Measurement of the bladder volume Immediately after procedure (urodynamics studies)
Primary Estimated Post Void Residue Estimated PVR Immediately after procedure (urodynamics studies)
Primary Drainage volume Residual urine drained by using a catheter Immediately after procedure (urodynamics studies)
See also
  Status Clinical Trial Phase
Recruiting NCT02978638 - Electrical Stimulation for Continence After Spinal Cord Injury N/A
Enrolling by invitation NCT06429631 - The Effect of CIC Education on QOL and Compliance With Mobile Application in Individuals With Spinal Cord Injury. N/A
Completed NCT03573726 - Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life N/A
Recruiting NCT06059066 - Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction N/A
Completed NCT01429090 - Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution Phase 1
Recruiting NCT05587101 - Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
Terminated NCT03843073 - Connected Catheter- Safety and Effectiveness Study N/A
Terminated NCT04059159 - Connected Catheter - Safety and Effectiveness Study N/A
Completed NCT05858840 - Urinary Artificial Sphincter in Children
Completed NCT05861024 - Urinary Calculi After Bladder Augmentation in Children
Completed NCT04074616 - Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation N/A
Completed NCT05683938 - GentleCathâ„¢ Air Intermittent Catheter Smartwatch Real Life Pilot Study
Active, not recruiting NCT06247033 - Efficacies of Different Managements in Patients With Overactive Bladder With Stroke N/A
Withdrawn NCT01305681 - Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization Phase 1/Phase 2
Recruiting NCT04248322 - Qualitative Assessment of the Impact of TTNS on QOL and Participation
Recruiting NCT05301335 - Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study N/A
Recruiting NCT04924569 - Continence Care Registry
Completed NCT01716624 - Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder Phase 3
Completed NCT01297647 - Incidence of Urinary Tract Infection After Urodynamic Investigation N/A
Recruiting NCT04373512 - Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury Phase 2